Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030?
One-OffHealth & MedicineRegulierung3JManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseJa 66.6%
Prognostiker
28
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 17 Stunden
Veraltet8. März 22, 09:01 UTC1. Jan. 30, 05:00 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will Xenobots Be Approved By The FDA Before 2030?
Manifold MarketsWill a vaccine for HIV be approved by the FDA by 2030?
Manifold MarketsWill the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Manifold MarketsWill the FDA approve MDMA for PTSD?
KalshiRaniPill microneedle pill to replace injections: approved for sale by the end of 2026?
FutuurTdi-11861 (a fast-acting male contraceptive) approved for human clinical trials by the end of 2026?
FutuurRegeln
This market resolves to 'YES' if the FDA announces approval of MDMA-assisted therapy for PTSD by January 1st, 2030.
- If approval is announced prior to market closing, then the market will resolve early.
- EDIT: If neither of these conditions are met, then the market will resolve to 'NO'
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 18.288,2 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5178,9 €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 weitere Ergebnisse
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Gesamtvolumen
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Gesamtvolumen
- 916.002,6 €
- 24h-Volumen
- 1515,1 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 weitere Ergebnisse
- Gesamtvolumen
- 863.640,2 €
- 24h-Volumen
- 1039 €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030??
- Manifold Markets bewertet Yes mit 67% (Stand: 8. September 2026).
- Wann wird Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030? entschieden?
- Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030? soll am 1. Januar 2030 entschieden werden.
- Wie wird Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: This market resolves to 'YES' if the FDA announces approval of MDMA-assisted therapy for PTSD by January 1st, 2030.